Literature DB >> 8562820

[Delegated prescription by specialists in primary care].

M P Arroyo1, E Cano, R Ansorena, J Celay, F Cortés, V Estremera.   

Abstract

OBJECTIVES: To describe the qualitative-quantitative features of Primary Care prescriptions originated by specialists.
DESIGN: A crossover descriptive study.
SETTING: Txantrea Health Centre (Pamplona). PATIENTS AND OTHER PARTICIPANTS: All the prescriptions originated by out-clinic or hospital specialists over a two-month period, in three Health Centre clinics.
MEASUREMENTS AND MAIN RESULTS: The number of prescriptions passed on to Primary Care was 3,009, costing 5,303,071 pesetas, which was 31.61% of the drugs prescribed and 38.08% of the pharmaceutical expenditure of the three clinics during the period under study. 65.88% of the prescriptions corresponded to out-clinic specialists and 34.11% to hospital specialists. They were not accompanied by a clinical note, the treatment and the length of treatment in 33.46%, 36.55% and 45.39% of cases, respectively. The group and sub-group with most prescriptions passed on were Cardiovascular Apparatus and Calcium antagonists. The commonest active principal was acetylsalicylic acid. 79.89% were taken orally, 88.20% were single drugs and 73.28% of the medicines had high intrinsic value.
CONCLUSIONS: An important proportion of Primary Care's pharmaceutical expenditure was identified as originating with specialists. There was scant information given for following up the patients. Improvement of communication between different care levels on the basis of common procedures and objectives would be a useful step towards better quality of care.

Entities:  

Mesh:

Year:  1995        PMID: 8562820

Source DB:  PubMed          Journal:  Aten Primaria        ISSN: 0212-6567            Impact factor:   1.137


  3 in total

1.  The cost of inadequate prescriptions for hypolipidaemic drugs. VICAF Group.

Authors:  L C Ballesteros; M I Fernández San Martín; T Sanz Cuesta; E Escortell Mayor; C López Bilbao
Journal:  Pharmacoeconomics       Date:  2001       Impact factor: 4.981

2.  [Evaluation of medical reports received from the second level of care].

Authors:  A Jiménez Marín; J Bellón Rodríguez; J Cordobés López; S Domínguez Palomo; F Martín Pérez; D Nieto Vizcaíno
Journal:  Aten Primaria       Date:  2001-04-15       Impact factor: 1.137

3.  [At what care level are cyclo-oxygenase-2 inhibitors prescribed?].

Authors:  M J Montero Fernández; F J Rodríguez Alcalá; N Valles Fernández; F López de Castro; M Esteban Tudela; B Cordero García
Journal:  Aten Primaria       Date:  2002-10-15       Impact factor: 1.137

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.